ArticleAnnals of clinical and translational neurology2026

Dimethyl Fumarate, But Not Rituximab, Reduces Serum GFAP Levels and PIRMA in Relapsing-Remitting MS.

F Shawket et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.